与同行伙伴构建"命运共同体" 新浪财经"酒价内参"重磅上线 知名白酒真实市场价尽在掌握 白酒行业史册里，1952年注定是浓墨重彩的一页——第一届全国评酒会上，西凤酒位列"中国四大名酒"。七十余年过去，白酒江湖早已沧海桑田， 而西凤酒却在岁月沉淀中历久弥新。如今，不管是在烟酒店，还是在宴席、老百姓餐桌上，都能见到西凤酒的身影。在白酒行业进入存量竞争的时 代，凤香型品类却连续多年保持增长，成为行业一抹亮色。这背后，是西凤酒在模式、生态、品牌等层面的持续升级。 老名酒"精准务实"的革新之路 "酒是陈的香，但做品牌不能因循守旧。"这是西凤酒多年实践得出的答案，但不是所有品牌都能以坚定的决心走一条革新之路。 白酒行业的黄金时代，OEM产品模式让很多品牌趋之若鹜。然而从2021年起，西凤酒宣布停止所有OEM产品要货计划，聚焦核心产品，持续开 展"品牌瘦身"。此后数年，西凤酒持续关停冗余产品条码，仅2024年便回收170余个，引导市场进一步向核心品牌聚焦。 与此同时，西凤酒将资源聚焦于凤香型产品品质的深度打造。在宝鸡凤翔的原产地，西凤酒建立了从原料种植到酿造生产的全产业链质控体系。通 过对传统工艺的坚守与现代品质管理的结合 ...

柯睿辰接任后，将全面负责宝马集团大中华区的业务，包括协调在中国的合资企业相关事务。他自1998 年加入宝马集团，历任集团销售体系多项重要管理职务。2010年至2018年，他负责宝马集团MINI品牌 在德国市场的业务。2018年至2021年，他出任宝马集团在德国市场的销售负责人。自2021年起，负责宝 马集团在北欧市场的销售业务，涵盖瑞典、挪威、丹麦和芬兰等市场。自2024年3月1日起，他开始领导 宝马集团在德国市场的整体业务运营。 新浪科技讯 1月31日上午消息，宝马集团宣布大中华区高层人事调整，自2026年4月1日起，柯睿辰将接 替高翔出任宝马集团大中华区总裁兼首席执行官。 高翔在宝马集团拥有超过三十年的销售和营销领域管理经验。在中国任职的12年间，他在推动宝马集团 电动化和数字化转型中发挥了关键作用。高翔将在完成其在中国的任期后，继续在宝马集团担任重要职 务。 "我们衷心感谢高翔多年来的倾力付出，以及在推动中国市场业务发展过程中做出的重要贡献。同时， 我们热烈欢迎柯睿辰履新。" 宝马集团负责客户、品牌及销售业务的董事高乐表示："在市场环境复杂 多变、竞争日益加剧的背景下，将区域管理经验有效运用于各核心市场 ...

Core Insights - The article highlights the transformation of Jiaozuo's cross-border e-commerce sector, showcasing the integration of traditional industries with digital trade, leading to significant growth in export capabilities [2][3][4] Group 1: Industry Growth - Jiaozuo's cross-border e-commerce import and export value is projected to exceed 10.6 billion yuan by 2025, reflecting a year-on-year growth of 6.9% [2] - The city has 42 enterprises listed in the provincial "source factory" directory, ranking third in the province, which enhances trust and facilitates smoother connections with buyers [2] Group 2: Policy and Infrastructure Development - The Jiaozuo Municipal Bureau of Commerce has implemented a comprehensive annual plan, investing over 3 million yuan to create an online service platform that integrates customs, logistics, finance, and credit supervision for a one-stop export service [3] - The establishment of a dual-core structure with a 5G industrial park in the north and a technology headquarters in the south promotes efficient resource aggregation [3] Group 3: Market Expansion Strategies - Jiaozuo is focusing on integrating domestic and foreign trade, with products like Meibo ceramics achieving success both overseas and domestically, demonstrating a dual empowerment strategy [3] - The city has identified 100 source factory profiles, with clear outlines for five major cross-border e-commerce industrial belts, including equipment manufacturing and new energy vehicle components [3] Group 4: Future Initiatives - Plans for 2023 include optimizing the online service platform, creating specialized cross-border e-commerce parks, and implementing a "source factory" scouting initiative to cultivate new foreign trade entities [3][4] - The establishment of a cross-border e-commerce association aims to encourage collective international expansion among enterprises and improve overseas warehouse layouts [3][4]

2025年银行的工作成效如何？2026年经营业务将如何安排？ 《国际金融报》记者注意到，1月下旬以来，六家国有大行、多家股份行和中小银行密集召开了 2026年度工作会议，承前启后，为迎接"十五五"开局之年做好布局。分机构类型来看，国有大行布局更 为全面，股份行立足优势追求差异化发展，中小银行则更侧重地方经济和改革化险。 例如，光大银行称，将坚持错位发展打造特色优势，推动营收稳健增长，提升客户经营价值，推动 存款成本改善，促进金市业务专业化经营，着力提高财富管理、投行、托管业务等中间业务收入贡献， 持续做好为基层赋能服务，加快推动数字化智能化转型。 平安银行则表示，将坚定贯彻党建引领业务发展，紧跟国家发展方向，积极融入集团"综合金融 +医疗养老"战略，锚定"全面深化改革落地、全效发挥综金优势、全力改善业绩表现"的发展目标，围 绕"两个坚持、两个把握"，即坚持"零售做强、对公做精、同业做专"战略不动摇；坚持降本增效、从严 治行要求不放松；把握"十五五"战略机遇，发掘新形势下银行发展新动能；把握科技革命时代机遇，将 科技战略作为银行发展核心驱动力，全面提升经营质效。 华夏银行称，2026年全行要紧紧围绕主要经营目标 ...

Core Viewpoint - The proposal by Song Dong emphasizes the need for Shandong Province to leverage new productivity to activate the agricultural industry chain, transitioning from a focus on scale advantages to quality and efficiency advantages, thereby injecting lasting momentum into rural revitalization [2][6]. Agricultural Industry Chain Development Challenges - Shandong has played a crucial role in ensuring national food security, with a total grain production exceeding 1.1 trillion jin for five consecutive years, and leading the nation in the production of vegetables, meat, eggs, and milk [6]. - The province's agricultural output value reached 1.31793 trillion yuan in 2025, with a year-on-year growth of 4.4% [6]. - Challenges include talent loss in rural areas, insufficient flow of high-end production factors, and a lack of effective agricultural operating entities, which hinder the overall efficiency of the agricultural industry chain [7]. Five Innovative Proposals for Agricultural Transformation - **Digital Breeding Innovation**: Establish an "AI + Seed Source" system to address high-end vegetable and livestock breeding issues, creating a digital breeding platform and providing subsidies for returning entrepreneurs [8][10]. - **Digital Transformation of Agriculture**: Implement a comprehensive digital transformation of agricultural production using AI and IoT technologies, enhancing smallholder farmers' digital capabilities and establishing smart farm demonstration zones [8][10]. - **Cross-Border Cold Chain Logistics**: Develop a digital cold chain logistics network to ensure the freshness and safety of agricultural products, integrating various services to facilitate rapid distribution of local specialties [10]. - **Entrepreneurial Ecosystem Development**: Create a cross-regional entrepreneurial incubation platform that supports innovation in agriculture through training and funding, encouraging young people to return to rural areas for entrepreneurship [10][11]. - **"Lu Nong Jia Xuan" Brand Initiative**: Build a multimedia marketing matrix around the "Lu Nong Jia Xuan" brand, enhancing product traceability and public trust while utilizing social media for promotion [11].

证券日报网讯1月30日，麦克奥迪（300341）在互动平台回答投资者提问时表示，公司管理层高度重视 股东利益，未来公司将继续加强技术创新和数字化转型，推动产品结构优化，在技术升级、全球化协同 与政策响应中寻找平衡，以韧性经营应对市场不确定性，努力为股东创造更大价值。 ...

Core Insights - The pharmaceutical industry is undergoing a digital transformation, with a structural change in the supply chain, shifting competition towards technology empowerment and model innovation [1] - The company, YaoYigou, is positioned as a leader in the A-share entrepreneurial board of the pharmaceutical supply chain, focusing on upgrading its core business while continuously investing in innovative ventures [1][2] - The market for pharmaceutical supply chains is expected to expand significantly, with sales projected to reach 2.95 trillion yuan by 2024, including a retail market of 650 billion yuan [1] Industry Trends - The integration of AI technology into the pharmaceutical supply chain is addressing traditional pain points such as slow inventory turnover and service homogenization [2] - The "AI empowerment + fundamental reversal" is anticipated to be a core growth engine for the industry, particularly as the AI medical sector is expected to reach a turning point by 2026 [1][2] Company Strategy - YaoYigou's core strategy involves leveraging technology to enhance its supply chain, with a focus on digitalization and intelligence [2] - The company has developed its own AI model, "Tokamak," which has reduced inventory turnover days to 28, nearing the efficiency of global leaders in AI healthcare [2] - The company has established a comprehensive service network covering 80,700 outpatient terminals and links with over 1,800 pharmaceutical companies, forming a complete industrial chain [2] Financial Performance - Despite facing short-term pressures from retail adjustments and shifts in grassroots demand, the company’s long-term strategy remains intact, presenting opportunities for capital market investments [3] - The innovative business segment is showing steady performance, contributing positively to revenue and profitability, and is expected to support the company's long-term value [3] Growth Opportunities - The company is actively pursuing multiple high-growth new sectors, including MAH (Marketing Authorization Holder), traditional Chinese medicine, new retail, chronic disease management, and AI healthcare [3] - The MAH business model is characterized by low investment and high returns, with several products in the pipeline expected to launch within two years, enhancing the company's bargaining power [3] - The chronic disease management sector has significant growth potential, given the market size of over 400 million chronic disease patients in China [3] Investment Outlook - Continuous investment in innovative business areas is crucial, even as these segments are still in the nurturing phase and may impact current profits [4] - The company is committed to long-term growth, with investments in cutting-edge technologies and applications in AI healthcare and big data, which are expected to enhance profitability and attract capital market attention [4] - The core pharmaceutical supply chain business is operating steadily, with efforts to optimize accounts receivable, reduce inventory, and tighten expenses to improve operational efficiency [4] Conclusion - The pharmaceutical industry is witnessing a multi-faceted growth trajectory, with YaoYigou's strategic positioning and innovative initiatives likely to attract ongoing capital market interest [5]

2025年，我国经济运行总体平稳、稳中有进，民航客运市场呈现稳健发展态势。公司坚持夯实安全基 础，持续优化航线网络布局，积极提升营销能力，不断创新服务品质，深入推进业财融合和成本管控， 加快推动数字化转型，经营效益显著改善。公司全年完成运输总周转量279.81亿吨公里，旅客运输量近 1.50亿人次，分别同比增长 10.82%和 6.68%，利润总额预计为人民币2亿元至3亿元，实现扭亏为盈。根 据会计准则，公司报告期内转回部分前期可抵扣亏损形成的递延所得税资产，增加所得税费用，导致公 司归属于上市公司股东净利润为负值。 格隆汇1月30日丨中国东航(600115.SH)公布，预计2025年度利润总额约为人民币2亿元至3亿元。公司预 计2025年度归属于上市公司股东的净利润约为人民币-13亿元至-18亿元。公司预计扣除非经常性损益事 项后，2025年度归属于上市公司股东的净利润约为人民币-27亿元至-33亿元。 ...

Group 1 - The core point of the announcement is that Shenzhou Holdings' indirect non-wholly-owned subsidiary, Shenzhou Information, is expected to turn a profit in 2025, with a projected net profit of between 46 million and 69 million RMB, following a loss of 524 million RMB in 2024 [1] - The significant growth in Shenzhou Information's performance is attributed to several factors: active market expansion leading to increased revenue, improved collection management resulting in better cash flow, and a notable decrease in goodwill impairment compared to the previous year [1] - Shenzhou Holdings holds approximately 38.7% of Shenzhou Information, meaning the substantial profit increase of Shenzhou Information will positively impact Shenzhou Holdings' overall performance in 2025 [1] Group 2 - In terms of business layout, the "Shenzhou system" consists of three companies, each focusing on different strategic areas: Shenzhou Holdings emphasizes big data and AI applications; Shenzhou Information focuses on financial technology with a "data-cloud integration" strategy; and Shenzhou Digital centers on cloud computing and digital transformation [2] - Recently, Shenzhou Holdings announced plans to sell up to 28.8273 million shares of Shenzhou Information, representing about 2.9543% of its total share capital, while ensuring that Shenzhou Information remains a subsidiary and that the collaboration between the two companies will not be affected [2] - The proceeds from the share sale are intended to support Shenzhou Holdings' own business development and to supplement general working capital, providing sufficient funding for its AI sector initiatives [2]

中国东方航空股份(00670)公布，按中国企业会计准则，预计2025年度利润总额约为人民币2亿元至3亿 元，预计2025年度归属于上市公司股东的净亏损约为人民币13亿元至18亿元，预计2025年度归属于上市 公司股东的扣除非经常性损益的净亏损约为人民币27亿元至33亿元。2024年度，公司亏损总额为人民币 39.04亿元;归属于上市公司股东的净亏损为人民币42.26亿元;归属于上市公司股东的扣除非经常性损益 的净亏损润为人民币49.83亿元。 2025年，我国经济运行总体平稳、稳中有进，民航客运市场呈现稳健发展态势。公司坚持夯实安全基 础，持续优化航线网络布局，积极提升营销能力，不断创新服务品质，深入推进业财融合和成本管控， 加快推动数字化转型，经营效益显著改善。公司全年完成运输总周转量279.81亿吨公里，旅客运输量近 1.50亿人次，分别同比增长10.82%和6.68%，利润总额预计为人民币2亿元至3亿元，实现扭亏为盈。根 据会计准则，公司报告期内转回部分前期可抵扣亏损形成的递延所得税资产，增加所得税费用，导致公 司归属于上市公司股东净利润为负值。 ...